Medical suppression of hypercortisolemia in Cushing's syndrome with particular consideration of etomidate. (Q37873797)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21556813%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

review article

1 reference

title

Medical suppression of hypercortisolemia in Cushing's syndrome with particular consideration of etomidate (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21556813%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

1 reference

1 reference

Ludwig Christian Hinske

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21556813%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

author name string

Jens Heyn

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21556813%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Carolin Geiger

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21556813%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Josef Briegel

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21556813%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Florian Weis

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21556813%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

language of work or name

1 reference

1 June 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21556813%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21556813%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21556813%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

page(s)

117-125

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21556813%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21556813%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s11102-011-0314-3

31 January 2020

exact match

0 references

cites work

Incidence and late prognosis of cushing's syndrome: a population-based study

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0314-3

Drugs in the medical treatment of Cushing's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0314-3

Severe hypercortisolism: a medical emergency requiring urgent intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0314-3

Cortisolemic indices predict severe infections in Cushing syndrome due to ectopic production of adrenocorticotropin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0314-3

Hypokalemia, diabetes mellitus, and hypercortisolemia are the major contributing factors to cardiac dysfunction in adrenal Cushing's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0314-3

The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0314-3

Diagnosis/differential diagnosis of Cushing's syndrome: a review of best practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0314-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0314-3

Successful long-term treatment of refractory Cushing's disease with high-dose mifepristone (RU 486).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0314-3

A novel use of etomidate for intentional adrenal suppression to control severe hypercortisolemia in childhood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0314-3

Surgery for Cushing's syndrome: an historical review and recent ten-year experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0314-3

Improved quality of life after bilateral laparoscopic adrenalectomy for Cushing's disease: a 10-year experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0314-3

A phase II trial of combination chemotherapy and surgical resection for the treatment of metastatic adrenocortical carcinoma: continuous infusion doxorubicin, vincristine, and etoposide with daily mitotane as a P-glycoprotein antagonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0314-3

Medical treatment of Cushing's syndrome: adrenal-blocking drugs and ketaconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0314-3

Therapy of Cushing's syndrome with steroid biosynthesis inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0314-3

Medical therapy of Cushing's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0314-3

Effect of pioglitazone on adrenocorticotropic hormone and cortisol secretion in Cushing's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0314-3

Acute effects of bromocriptine, cyproheptadine, and valproic acid on plasma adrenocorticotropin secretion in Nelson's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0314-3

Coexpression of dopamine and somatostatin receptor subtypes in corticotroph adenomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0314-3

Alternative promoter usage and tissue specific expression of the mouse somatostatin receptor 2 gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0314-3

The multi-ligand somatostatin analogue SOM230 inhibits ACTH secretion by cultured human corticotroph adenomas via somatostatin receptor type 5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0314-3

Pharmacological management of Cushing's syndrome: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0314-3

Aminoglutethimide: review of pharmacology and clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0314-3

Aminoglutethimide in the treatment of Cushing's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0314-3

Ketoconazole blocks adrenal steroidogenesis by inhibiting cytochrome P450-dependent enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0314-3

Treatment of Cushing's disease by O,p'DDD. Survey of 62 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0314-3

Sustained Remission of Cushing's Disease with Mitotane and Pituitary Irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0314-3

Merits and pitfalls of mifepristone in Cushing's syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0314-3

Etomidate infusion in the critical care setting for suppressing the acute phase of Cushing's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0314-3

Efficient short-term control of hypercortisolaemia by low-dose etomidate in severe paediatric Cushing's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0314-3

Emergency and prolonged use of intravenous etomidate to control hypercortisolemia in a patient with Cushing's syndrome and peritonitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0314-3

Etomidate use for Cushing's syndrome caused by an ectopic adrenocorticotropic hormone-producing tumor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0314-3

Activation of α2B-Adrenoceptors Mediates the Cardiovascular Effects of Etomidate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0314-3

The inhibition by etomidate of the 11 beta-hydroxylation of cortisol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0314-3

Excitatory effects and electroencephalographic correlation of etomidate, thiopental, methohexital, and propofol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0314-3

Comparison of ICI 35868, etomidate and methohexitone for day-case anaesthesia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0314-3

Comparison of induction characteristics of four intravenous anaesthetic agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0314-3

Effects of thiopentone, etomidate and propofol on beat-to-beat cardiovascular signals in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0314-3

Acute adrenal insufficiency after a single dose of etomidate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0314-3

Infusion of low dose etomidate: correction of hypercortisolemia in patients with Cushing's syndrome and dose-response relationship in normal subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0314-3

Long-term etomidate and adrenocortical suppression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0314-3

Effect of etomidate on hypercortisolism due to ectopic ACTH production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0314-3

Nonhypnotic low-dose etomidate for rapid correction of hypercortisolaemia in cushing's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0314-3

Transsphenoidal hypophysectomy of a patient with an ACTH-producing pituitary adenoma and an "empty sella" after pretreatment with etomidate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0314-3

Treatment of severe psychosis due to ectopic Cushing's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0314-3

Direct inhibitory effect of etomidate on corticosteroid secretion in human pathologic adrenocortical cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0314-3

Propranolol Therapy for Ectopic β-Adrenergic Receptors in Adrenal Cushing's Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0314-3

Efficacy of Adjuvant Radiotherapy of the Tumor Bed on Local Recurrence of Adrenocortical Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-011-0314-3

Cushing's syndrome--killing disease: discriminatory value of signs and symptoms aiding early diagnosis

21 January 2018

1 reference

12 December 2020

Synchronous bilateral adrenalectomy for adrenocorticotropic-dependent Cushing's syndrome

1 reference

12 December 2020

Results of adrenal surgery for Cushing's syndrome: 10 years' experience

1 reference

12 December 2020

Use of a parenteral propylene glycol-containing etomidate preparation for the long-term management of ectopic Cushing's syndrome

1 reference

12 December 2020

New insights on SOM230, a universal somatostatin receptor ligand.

1 reference

12 December 2020

Medical management of Cushing disease

1 reference

12 December 2020

The plasma protein binding and distribution of etomidate in dog, rat and human blood

1 reference

12 December 2020

Failure of long-term therapy with sodium valproate in Cushing's disease

1 reference

12 December 2020

Incidence and Late Prognosis of Cushing’s Syndrome: A Population-Based Study1

1 reference

12 December 2020

Compatibility of etomidate, thiopental sodium, and propofol injections with drugs commonly administered during induction of anesthesia.

1 reference

12 December 2020

Phase II evaluation of cisplatin and etoposide followed by mitotane at disease progression in patients with locally advanced or metastatic adrenocortical carcinoma: a Southwest Oncology Group Study

1 reference

12 December 2020

Differential effects of the imidazole derivatives etomidate, ketoconazole and miconazole and of metyrapone on the secretion of cortisol and its precursors by human adrenocortical cells

1 reference

12 December 2020

Pharmacokinetics of etomidate, a new intravenous anesthetic

1 reference

12 December 2020

Suppression of ectopic adrenocorticotropin secretion by the long-acting somatostatin analog octreotide

1 reference

12 December 2020

Pharmacokinetics of etomidate in surgical patients

1 reference

12 December 2020

Prognostic parameters of metastatic adrenocortical carcinoma

1 reference

12 December 2020

The protracted effect of o,p'-DDD in Cushing's disease and its impact on adrenal morphogenesis of young human embryo

1 reference

12 December 2020

Cyproheptadine-Induced Remission of Cushing's Disease

1 reference

12 December 2020

Effects of Aminoglutethimide Upon Adrenal Function and Cortisol Metabolism in Cushing's Syndrome

1 reference

12 December 2020

Radiation Therapy for Adjunctive Treatment of Adrenal Cortical Carcinoma

1 reference

12 December 2020

Leuprolide acetate therapy in luteinizing hormone--dependent Cushing's syndrome

1 reference

12 December 2020

Medical management of Cushing disease

1 reference

12 December 2020

10.1007/S11102-011-0314-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21556813%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

1 reference